Publications

CAR-T

Publications

Follicle-stimulating Hormone Receptor is Expressed by Most Ovarian Cancer Subtypes and is a Safe and Effective Immunotherapeutic Target

Breast Cancer Vaccine

Publications

Targeted Vaccination against Human α-Lactalbumin for Immunotherapy and Primary Immunoprevention of Triple Negative Breast Cancer

COVID-19

Publications

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

Latest News & Events

Sep 8, 2020

Anixa Biosciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment Conference

Read More...

Aug 13, 2020

Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds

Read More...

Jul 28, 2020

Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission

Read More...